0xbtFeed TIMEZONE: London, UK (GMT+1)
Blockonomi
Cryptocurrency News & Your Guide to the Blockchain Economy
02/24/2026 02:49 PM Constellation Energy (CEG) Stock Rises After Q4 Earnings Beat
TLDR Constellation Energy reported Q4 adjusted EPS of $2.30, beating the $2.25 analyst estimate Operating revenue came in at $6.07 billion, well above the $4.82 billion forecast The company raised its quarterly dividend to 42.65 cents from 38.78 cents 2026 guidance was not issued — investors will have to wait until March 31 CEG stock [...]
The post Constellation Energy (CEG) Stock Rises After Q4 Earnings Beat appeared first on Blockonomi.
02/24/2026 02:44 PM Cipher Digital (CIFR) Stock Drops on Earnings Miss as AWS Deal Takes Center Stage
TLDR Cipher Digital (formerly Cipher Mining) reported Q4 revenue of $60M, missing the $84.4M estimate Adjusted EPS came in at a loss of $0.14, wider than the forecast loss of $0.06 The company rebranded to reflect a pivot from bitcoin mining to high-performance computing (HPC) Cipher secured 600 MW of contracted capacity, including deals with [...]
The post Cipher Digital (CIFR) Stock Drops on Earnings Miss as AWS Deal Takes Center Stage appeared first on Blockonomi.
02/24/2026 02:39 PM IBM Stock Just Had Its Worst Day Since 2000 – Jefferies Says Buy the Dip
TLDR IBM stock has dropped 28.6% in under a month, falling from $312.95 to $223.35 The selloff was triggered by Anthropic highlighting COBOL functionality in Claude Code, raising fears AI could erode IBM’s legacy business Jefferies analyst Brent Thill maintained a Buy rating with a $370 price target, calling the dip a buying opportunity IBM’s [...]
The post IBM Stock Just Had Its Worst Day Since 2000 – Jefferies Says Buy the Dip appeared first on Blockonomi.
02/24/2026 02:32 PM Nvidia (NVDA) Stock: Wedbush and Truist Reiterate Buy Ahead of Earnings Wednesday
TLDR Nvidia reports Q4 FY26 earnings on February 25, with revenue forecast up 68% year-over-year to $66.1 billion. Wedbush reiterates Buy with a $230 price target; Truist holds Buy at $275. Wall Street consensus is Strong Buy — 32 Buys, one Sell — with an average target of $265.07. Competition from hyperscaler-designed chips and TSMC [...]
The post Nvidia (NVDA) Stock: Wedbush and Truist Reiterate Buy Ahead of Earnings Wednesday appeared first on Blockonomi.
02/24/2026 02:28 PM Intel (INTC) Stock: Invests in SambaNova’s $350M Round After Buyout Talks Fell Apart
TLDR Intel is joining a $350M funding round for AI chip startup SambaNova Systems. The two companies are forming a multiyear partnership using Intel server chips and GPUs. Intel CEO Lip-Bu Tan has chaired SambaNova since 2017 and previously tried to buy it for $1.6B. SambaNova’s new SN50 chip claims to outperform Nvidia’s B200 GPUs [...]
The post Intel (INTC) Stock: Invests in SambaNova’s $350M Round After Buyout Talks Fell Apart appeared first on Blockonomi.
02/24/2026 02:23 PM Microsoft (MSFT) Stock: Citi and Goldman Sachs Reiterate Buy Ratings – Here’s Why
TLDR Citi and Goldman Sachs both maintain Buy ratings on Microsoft stock Q2 revenue hit $81.3B, up 17% YoY; net income rose 60% to $38.5B Azure grew 39% YoY; Copilot seats up 160% to 15 million paid users Maia 200 chip now performs closer to Amazon and Google rivals 41 of 50 analysts rate MSFT [...]
The post Microsoft (MSFT) Stock: Citi and Goldman Sachs Reiterate Buy Ratings – Here’s Why appeared first on Blockonomi.
02/24/2026 02:19 PM Novo Nordisk (NOVO.B) Stock: The $2 Billion Weight Loss Drug That Just Proved Its Worth
TLDR UBT251 produced mean weight loss of up to 19.7% after 24 weeks in a mid-stage Chinese trial The drug targets three hormones — GLP-1, GIP, and glucagon — earning it the “triple G” label Side effects were mild to moderate and decreased over time Results arrive one day after CagriSema failed to beat Eli [...]
The post Novo Nordisk (NOVO.B) Stock: The $2 Billion Weight Loss Drug That Just Proved Its Worth appeared first on Blockonomi.
02/24/2026 02:10 PM Vir Biotechnology (VIR) Stock: Reaches 52-Week High as Three Big Catalysts Hit at Once
TLDR VIR stock jumped ~60% in premarket Tuesday after a major Astellas Pharma partnership for prostate cancer drug VIR-5500 The deal includes $335M upfront, plus up to $1.37B in future milestone payments Phase 1 data showed an 82% PSA50 decline rate in the highest dose patient group Q4 loss of 31 cents beat the 41-cent [...]
The post Vir Biotechnology (VIR) Stock: Reaches 52-Week High as Three Big Catalysts Hit at Once appeared first on Blockonomi.
02/24/2026 02:05 PM PayPal (PYPL) Stock: Takeover Report Sends Stock Surging 9%
TLDR PayPal surged up to 9% Monday after Bloomberg reported the company has attracted unsolicited takeover interest. At least one large rival is eyeing a full acquisition; others are interested in specific assets only. Trading was briefly halted for volatility before closing up 5.8% at $44.05 — the top S&P 500 stock that day. The [...]
The post PayPal (PYPL) Stock: Takeover Report Sends Stock Surging 9% appeared first on Blockonomi.
02/24/2026 01:50 PM Lemonade (LMND) Stock Falls as Piper Sandler Cuts Price Target to $65 After Earnings
TLDR LMND stock dropped 10–12% in the days after its Q4 2025 earnings release Q4 revenue hit $228.1 million, up 53% year-over-year, but losses continue 2026 guidance projects an adjusted EBITDA loss of $48–$52 million Piper Sandler cut its price target from $85 to $65, keeping a Neutral rating Full-year EBITDA profitability is now targeted [...]
The post Lemonade (LMND) Stock Falls as Piper Sandler Cuts Price Target to $65 After Earnings appeared first on Blockonomi.
2019 ©